Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | EW0169 | IM |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EW0179 | IM |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Pulmonary embolisms (bilateral), DVTs, triple positive antiphospholipid antibodies, elevated ANA (previously normal), acute kidney injury. Prior to hospitalization she had 1 month of progressive myalgias, arthralgias, fatigue, poor oral intake. She had AKI on admission to hospital and concern for autoimmune cause.
anemia (mild), aortic atherosclerosis, carotid atherosclerosis, spondylosis, mild ascending aorta dilation, gallstones
multivitamin
None
Kidney biopsy, ultrasound, CT chest, ANA Positive 1:1280 speckled, Cr 2.26, CRP 02.6, Smith AB >8, RNP ab >3.5, SPEP abnormal restricted peak in gamma region, IgG Lambda paraprotein, positive lupus anticoagulant, beta-2 glycoprotein IgM, anticardiolipin IgM), renal biopsy without evidence of lupus